Legal & General Group PLC Beam Therapeutics Inc. Transaction History

Legal & General Group PLC

  • $440 Billion
  • Q2 2024

A detailed history of Legal & General Group PLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 78,373 shares of BEAM stock, worth $1.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
78,373
Previous 73,558 6.55%
Holding current value
$1.96 Million
Previous $2.43 Million 24.44%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$21.22 - $32.66 $102,174 - $157,257
4,815 Added 6.55%
78,373 $1.84 Million
Q1 2024

May 14, 2024
BUY
$23.46 - $45.07 $70,614 - $135,660
3,010 Added 4.27%
73,558 $2.43 Million
Q4 2023

Feb 15, 2024
BUY
$17.69 - $30.76 $14,541 - $25,284
822 Added 1.18%
70,548 $1.92 Million
Q3 2023

Nov 14, 2023
BUY
$23.01 - $32.46 $332,793 - $469,468
14,463 Added 26.17%
69,726 $1.68 Million
Q2 2023

Aug 14, 2023
SELL
$29.32 - $35.99 $26,124 - $32,067
-891 Reduced 1.59%
55,263 $1.76 Million
Q1 2023

May 15, 2023
BUY
$30.15 - $48.79 $88,309 - $142,905
2,929 Added 5.5%
56,154 $1.72 Million
Q4 2022

Feb 14, 2023
SELL
$36.73 - $51.6 $24,205 - $34,004
-659 Reduced 1.22%
53,225 $2.08 Million
Q3 2022

Nov 14, 2022
SELL
$39.79 - $70.31 $105,045 - $185,618
-2,640 Reduced 4.67%
53,884 $2.57 Million
Q2 2022

Aug 22, 2022
BUY
$29.86 - $62.36 $413,949 - $864,496
13,863 Added 32.5%
56,524 $2.19 Million
Q1 2022

May 16, 2022
BUY
$53.73 - $82.16 $229,695 - $351,234
4,275 Added 11.14%
42,661 $2.45 Million
Q4 2021

Feb 14, 2022
BUY
$68.02 - $99.06 $80,195 - $116,791
1,179 Added 3.17%
38,386 $3.06 Million
Q3 2021

Nov 15, 2021
BUY
$84.37 - $133.6 $666,860 - $1.06 Million
7,904 Added 26.97%
37,207 $3.24 Million
Q2 2021

Aug 12, 2021
BUY
$64.12 - $128.71 $263,404 - $528,740
4,108 Added 16.3%
29,303 $3.77 Million
Q1 2021

May 17, 2021
BUY
$71.28 - $120.75 $1.21 Million - $2.05 Million
16,994 Added 207.22%
25,195 $2.02 Million
Q4 2020

Feb 12, 2021
BUY
$22.24 - $95.63 $71,390 - $306,972
3,210 Added 64.32%
8,201 $669,000
Q3 2020

Nov 13, 2020
BUY
$19.0 - $30.57 $42,940 - $69,088
2,260 Added 82.75%
4,991 $123,000
Q2 2020

Aug 14, 2020
BUY
$15.26 - $28.66 $12,574 - $23,615
824 Added 43.21%
2,731 $77,000
Q1 2020

May 14, 2020
BUY
$13.31 - $29.2 $25,382 - $55,684
1,907 New
1,907 $34,000

Others Institutions Holding BEAM

# of Institutions
230
Shares Held
73.6M
Call Options Held
283K
Put Options Held
233K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.76B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email